Labandero, Venancio B.

HRN: 12-13-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2024
CEFTRIAXONE 1G (VIAL)
04/11/2024
04/17/2024
IV
2g
OD
Perforated PUD
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: